June 8, a group of Shenzhen Children’s Hospital delegates visited SZBL. Led by Hospital President Ma Xiaopeng and Vice President Li Defa, the delegation was joined by representatives from different pediatric specialties and research departments. SZBL leadership including Wu Yun-Dong and Tu Huan welcomed and met with the delegation. The visit improved communication for further cooperation between the research and the clinical sectors.

At the exhibition hall of SZBL, Ma Xiaopeng and his delegation were given an introduction on the overall development of the laboratory. Dr. Zhang Xinhao, Assistant to the SZBL Director, highlighted the scientific system and mechanism, organizational structure, research groups and technology platforms of SZBL during his introduction.

SZBL Executive Vice Director Wu Yun-Dong extended warm welcome to the delegation at the meeting. He said that SZBL values clinical cooperation with hospitals and had already developed a number of hospital partners. Shenzhen Children’s Hospital and SZBL can conduct further discussion on cooperation and seek joint efforts on research of hematological malignancies, epilepsy, autism, gene therapeutics and medical imaging for greater sustainable development.

Shenzhen Children’s Hospital President Ma Xiaopeng introduced the establishment and key clinical specialties of the hospital. He said that as a 3A-graded public hospital, the work of Shenzhen Children’s Hospital was fueled by extensive clinical practices coupled with a system comprehensively combining healthcare, education, research and management. Ma Xiaopeng continued to add that the Children’s Hospital offers rich clinical resources and bio samples that are essential for pediatric research, which can serve as a complementary strength for cooperation with SZBL to enhance the health and well-being of children.

SZBL scientists including Zhou Lei, Niu Tianye, Zhang Bo, Sun Kun, Cheng Zhicheng, Deng Lin, Li Gang, Liu Qi and Wang Yingjie attended the meeting and shared on individual research. In-depth discussion on autism, gene therapeutics, medical imaging diagnosis and treatment, and microbiology research were conducted on the meeting.